Clinical Trial Details


Back to Clinical Trials Database

Randomized phase III trial. Post-operative adjuvant Interferon-alpha 2b (Intron-A) treatment after resection of thick primary melanoma and/or regional lymphnode metastases "intermediate-high dose" vs "intermediate-low dose" Interferon-alpha vs observation.

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 20-Mar-1996
Date Step1 close: 15-Jun-2000
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 1400
Study Staff
Type of cancer
Participating groups
Protocol summary
NCT number NCT00002763